Francesca Saffioti
Overview
Explore the profile of Francesca Saffioti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
693
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lam L, Soret P, Lemoinne S, Hansen B, Hirschfield G, Gulamhusein A, et al.
Clin Gastroenterol Hepatol
. 2024 Jul;
22(12):2432-2441.e2.
PMID: 39019421
Background & Aims: In primary biliary cholangitis (PBC), static liver stiffness measurement (LSM) has proven prognostic value. However, the added prognostic value of LSM time course in this disease remains...
2.
Snir T, Greenman R, Aricha R, Frankel M, Lawler J, Saffioti F, et al.
Int J Mol Sci
. 2024 Jun;
25(11).
PMID: 38892228
Primary sclerosing cholangitis (PSC) is a rare, progressive disease, characterized by inflammation and fibrosis of the bile ducts, lacking reliable prognostic biomarkers for disease activity. Machine learning applied to broad...
3.
Mavroeidis V, Knapton J, Saffioti F, Morganstein D
World J Diabetes
. 2024 Apr;
15(4):598-605.
PMID: 38680702
Pancreatic surgery units undertake several complex operations, albeit with considerable morbidity and mortality, as is the case for the management of complicated acute pancreatitis or chronic pancreatitis. The centralisation of...
4.
Motta R, Saffioti F, Mavroeidis V
World J Gastroenterol
. 2024 Apr;
30(13):1836-1850.
PMID: 38659478
The term hepatolithiasis describes the presence of biliary stones within the intrahepatic bile ducts, above the hilar confluence of the hepatic ducts. The disease is more prevalent in Asia, mainly...
5.
Kaur S, Motta R, Chapman B, Wharton V, Collier J, Saffioti F
World J Hepatol
. 2024 Apr;
16(3):428-438.
PMID: 38577536
Background: Long-term abdominal drains (LTAD) are a cost-effective palliative measure to manage malignant ascites in the community, but their use in patients with end-stage chronic liver disease and refractory ascites...
6.
Greenman R, Snir T, Katav A, Aricha R, Mishalian I, Hay O, et al.
Cells
. 2024 Feb;
13(3.
PMID: 38334601
Primary sclerosing cholangitis (PSC) is an inflammatory and fibrotic biliary disease lacking approved treatment. We studied CCL24, a chemokine shown to be overexpressed in damaged bile ducts, and its involvement...
7.
Saffioti F, Mavroeidis V
Hepatobiliary Surg Nutr
. 2024 Feb;
13(1):172-175.
PMID: 38322224
No abstract available.
8.
Colosimo S, Bertoli S, Saffioti F
Nutrients
. 2023 Oct;
15(19).
PMID: 37836474
Advanced chronic liver disease (ACLD) represents a complex and multifactorial clinical entity characterized by liver dysfunction and associated complications. In recent years, the significance of nutritional status in ACLD prognosis...
9.
Roccarina D, Saffioti F, Rosselli M, Marshall A, Pinzani M, Thorburn D
JHEP Rep
. 2023 Sep;
5(11):100873.
PMID: 37771366
Background & Aims: Liver stiffness measurement (LSM) and spleen stiffness measurement (SSM) have been shown to be useful tools for assessing the risk of fibrosis and portal hypertension, respectively. However,...
10.
Corpechot C, Lemoinne S, Soret P, Hansen B, Hirschfield G, Gulamhusein A, et al.
Hepatology
. 2023 Jul;
79(1):39-48.
PMID: 37399238
Background And Aims: Normal alkaline phosphatase (ALP) levels in ursodeoxycholic acid (UDCA)-treated patients with primary biliary cholangitis (PBC) are associated with better long-term outcome. However, second-line therapies are currently recommended...